ADA Salivary Diagnostics Summit Signals a New Way to Predict Your Child's Cavity Risk
The American Dental Association held its first Salivary Diagnostics Summit on June 18, 2026, at its Chicago headquarters, where researchers said saliva testing technology has finally caught up to decades of science and could soon help dentists spot cavity risk, gum disease, and other health problems earlier, including in children. The tests are not yet a routine part of a child's checkup, but the ADA's own coverage of the summit signals this is now a matter of when, not if, for family dental practices.
What did the ADA's Salivary Diagnostics Summit actually announce?
The summit did not announce a new product or a new guideline. It brought together researchers, clinicians, and industry figures to examine whether saliva testing is ready to move from research labs into everyday dental practices, according to the American Dental Association's July 2026 recap. Keynote speaker Dr. Debora Heller, immediate past president of the Salivary Research Group at the International Association for Dental, Oral, and Craniofacial Research, told attendees, "I want to tell you that the science is here. And I want us together to move it from evidence to implementation." She added, "Finally, the technology has caught up with the biology."
Dr. Maria Ryan, vice president and chief dental officer at Colgate, discussed how salivary testing fits into a broader push toward precision, personalized dental medicine rather than the traditional look and probe exam. The ADA's own recap notes that saliva already carries proteins, DNA, RNA, and microbial signatures tied to periodontal disease, oral cancer, dry mouth, diabetes, cardiovascular disease, and cavities, which is why the association convened specialists to weigh how, and how soon, dentists could put that information to work at the chairside.
How do dentists check a child's cavity risk today?
Right now, a child's cavity risk is judged mostly by history and a visual exam, not a lab test. The American Academy of Pediatric Dentistry's caries risk assessment policy, adopted in 2002 and last revised in 2019 with its current version updated in 2022, states plainly that "sufficiently validated multivariate screening tools to determine which children are at higher risk for dental caries are limited." Only two tools, Cariogram and CAMBRA, have real clinical validation. Dentists weigh social and behavioral factors such as sugar intake and access to care, clinical signs such as visible plaque or enamel defects, protective factors such as fluoridated water and toothpaste, and any existing cavities or restorations, then sort a child into a low, moderate, or high risk category starting at the age one dental visit.
That system works, but it leans heavily on what a dentist can see and what a parent reports, not on a direct biological measurement of a child's cavity causing bacteria or the protective minerals in their saliva.
What could salivary biomarker testing add for kids specifically?
Cavities remain the single most common chronic disease of American childhood. Data compiled by the Centers for Disease Control and Prevention's National Center for Health Statistics, covering 2017 through March 2020, shows 46.0 percent of children ages 2 to 19 have had untreated or restored dental caries in at least one primary or permanent tooth. A test that reads bacterial load, saliva flow, and buffering capacity directly, rather than inferring risk from checklists, could in theory flag a high risk toddler before a cavity ever forms, letting a pediatric dentist intervene with fluoride varnish, diet counseling, or closer recall visits sooner.
Saliva testing could also catch problems checklists miss entirely. The ADA's recap of the summit notes that more than 42 percent of medications carry dry mouth as a side effect, and reduced saliva flow is itself a major risk factor for cavities because saliva neutralizes acid and delivers calcium and phosphate back to the teeth. Children on long term asthma inhalers, allergy medication, or ADHD medication, all common in kids, could be exactly the group a saliva test flags that a visual exam alone would not.
| Factor | Today's checkup approach | What a salivary biomarker approach adds |
|---|---|---|
| What is measured | Visible plaque, enamel defects, cavity history, reported diet and habits | Bacterial load, salivary flow, buffering capacity, and other biological markers directly |
| Validated tools available | Cariogram and CAMBRA, per AAPD's 2022 policy | Still moving from research to routine practice, per the ADA's 2026 summit |
| Best at catching | Existing decay and obvious risk factors like poor access to care | Hidden risk, such as low saliva flow from a child's medication |
| Availability at a family dentist today | Standard at nearly every pediatric and family dental visit | Not yet routine, still being evaluated for clinical use |
Is this available at my child's dentist now?
Not as a standard part of a checkup. The summit itself was framed around moving the science "from evidence to implementation," language that signals the profession is still working out exactly how and when salivary testing gets built into everyday visits, not that it has already arrived in every operatory. For now, the caries risk conversation most families will have is still the traditional one built on the AAPD's existing framework, the kind offered by pediatric practices such as Bauer Dentistry and Orthodontics in Wheaton, Illinois, not far from where the ADA summit itself took place in Chicago.
Parents who want to understand what actually raises a young child's cavity risk today, ahead of any future biomarker test, can also look at how early those risk factors take hold. Our earlier coverage of a 2026 study that followed 3,196 children from birth found how young cavities can begin and which household factors raise the odds, which is exactly the kind of information a future salivary test would aim to confirm biologically rather than by history alone.
What should parents ask at the next checkup?
Families do not need to wait for saliva testing to become routine to have a more useful caries risk conversation now. Worth asking a pediatric or family dentist: which risk category does the AAPD's assessment place my child in, and why, does my child's asthma, allergy, or ADHD medication reduce saliva flow enough to matter, and is fluoride varnish or a shorter recall interval appropriate given that risk level. Those questions use the validated tools dentists already have, while the salivary biomarker approach discussed at the ADA summit continues moving toward clinical use.
FAQ
- Is salivary biomarker testing for cavities available at pediatric dentists today? Not as a routine part of checkups. The ADA's June 2026 summit focused on moving the underlying science toward clinical implementation, according to the ADA's July 2026 recap, rather than announcing that testing is already standard.
- What percentage of children currently have cavities? 46.0 percent of children ages 2 to 19 have untreated or restored dental caries in at least one tooth, according to CDC National Center for Health Statistics data covering 2017 to March 2020.
- What tools do dentists currently use to judge a child's cavity risk? The two clinically validated tools are Cariogram and CAMBRA, per the American Academy of Pediatric Dentistry's caries risk assessment policy, last updated in 2022.
- Why does saliva matter for cavities beyond bacteria? Saliva neutralizes acid and redeposits minerals onto teeth, so reduced flow, which the ADA notes is a side effect of more than 42 percent of medications, is itself a cavity risk factor.
Updated July 2026.
